These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

157 related articles for article (PubMed ID: 2583595)

  • 1. Relationship between adenosine deaminase activity (ADA) and inosinemonophosphate (IMP) accumulation in fresh erythrocytes incubated with adenosine and dipyridamole.
    Kopff M; Zakrzewska I; Klem J; Strzelczyk M
    Haematologia (Budap); 1989; 22(3):161-7. PubMed ID: 2583595
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Effect of dipyridamole on adenosine incorporation into hypoxanthine nucleotides of fresh human red cells.
    Kopff M; Zakrzewska I; Klem J; Zachara B
    Haematologia (Budap); 1986; 19(2):89-94. PubMed ID: 3758842
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Effect of dipyridamole on adenine incorporation into hypoxanthine nucleotides of fresh red blood cells.
    Kopff M; Zakrzewska I; Klem J; Zachara B
    Biomed Biochim Acta; 1986; 45(7):945-8. PubMed ID: 3790106
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Effect of dipyridamole on inosine triphosphate pyrophosphohydrolase activity and inosine triphosphate content in fresh human erythrocytes incubated with adenosine.
    Kopff M; Klem J; Zakrzewska I; Strzelczyk M
    Acta Biochim Pol; 1990; 37(2):227-32. PubMed ID: 1963521
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Purine nucleoside metabolism in the erythrocytes of patients with adenosine deaminase deficiency and severe combined immunodeficiency.
    Agarwal RP; Crabtree GW; Parks RE; Nelson JA; Keightley R; Parkman R; Rosen FS; Stern RC; Polmar SH
    J Clin Invest; 1976 Apr; 57(4):1025-35. PubMed ID: 947948
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Incorporation of adenosine and adenine into hypoxanthine nucleotides of fresh red blood cells.
    Kopff M
    Blut; 1986 Oct; 53(4):347-50. PubMed ID: 3756359
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Hypoxanthine nucleotides synthesis in fresh and stored human erythrocytes.
    Zachara B; Klem J; Kopff M
    Acta Biol Med Ger; 1981; 40(4-5):683-9. PubMed ID: 7315115
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Accumulation of inosine 5'-monophosphate in human erythrocytes incubated with inosine.
    Tomoda A; Yagawa K; Yoneyama Y
    Biomed Biochim Acta; 1987; 46(2-3):S280-4. PubMed ID: 2439075
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Activity of adenosine deaminase in red blood cells of patients suffering from multiple sclerosis treated with adrenocorticotropic hormone.
    Kopff M; Zakrzewska I; Klem J; Puczkowski S; Strzelczyk M; Czernicki J; Chmielewski H
    Pol J Pharmacol; 1995; 47(6):525-30. PubMed ID: 8868375
    [TBL] [Abstract][Full Text] [Related]  

  • 10. [Pathogenetic significance of adenosine deaminase in autoimmune diseases].
    Sasaki S
    Nihon Seikeigeka Gakkai Zasshi; 1984 Feb; 58(2):219-30. PubMed ID: 6332160
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Adenosine deaminase levels in construction workers with asbestos contact dermatitis.
    Formeister JF; Trisch GL; Mittleman A
    J Med; 1978; 9(4):285-90. PubMed ID: 154541
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Preservation of red blood cells with purines and nucleosides. III. Synthesis of adenine, guanine, and hypoxanthine nucleotides.
    Strauss D; de Verdier CD
    Folia Haematol Int Mag Klin Morphol Blutforsch; 1980; 107(3):434-53. PubMed ID: 6159281
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Mechanism of adenosine triphosphate catabolism induced by deoxyadenosine and by nucleoside analogues in adenosine deaminase-inhibited human erythrocytes.
    Bontemps F; Van den Berghe G
    Cancer Res; 1989 Sep; 49(18):4983-9. PubMed ID: 2788493
    [TBL] [Abstract][Full Text] [Related]  

  • 14. [Adenosine deaminase activity in hemoblastoses].
    Krüger W; Müller G; Storch H; Kubel M; Richter V
    Arch Geschwulstforsch; 1983; 53(1):53-9. PubMed ID: 6574729
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Effect of cardiovascular drugs on adenosine deaminase activity.
    Kowalczyk E; Kopff M; Kowalski J; Kopff A; Mikhailidis DP; Barylski M; Banach M
    Angiology; 2008 Dec-2009 Jan; 59(6):740-4. PubMed ID: 18840621
    [TBL] [Abstract][Full Text] [Related]  

  • 16. [Adenosine deaminase activity in leukemia patients].
    Müller G; Krug K; Richter V; Krüger W; Rassoul F
    Folia Haematol Int Mag Klin Morphol Blutforsch; 1981; 108(6):763-8. PubMed ID: 6176499
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Use of the integrated steady state rate equation to investigate product inhibition of human red cell adenosine deaminase and its relevance to immune dysfunction.
    Osborne WR; Chen SH; Scott CR
    J Biol Chem; 1978 Jan; 253(2):323-5. PubMed ID: 618871
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Effect of an adenosine deaminase inhibitor on the uptake and metabolism of arabinosyl adenine (Vidarabine) by intact human erythrocytes.
    Chang T; Glazko AJ
    Res Commun Chem Pathol Pharmacol; 1976 May; 14(1):127-40. PubMed ID: 935646
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Erythrocyte-specific overproduction of adenosine deaminase: molecular genetic studies.
    Chottiner EG; Gribbin TE; Ginsburg D; Mitchell BS
    Prog Clin Biol Res; 1989; 319():55-64; discussion 65-8. PubMed ID: 2622927
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Quantitative measurement of adenosine deaminase from human erythrocytes.
    Körber W; Meisterernst EB; Hermann G
    Clin Chim Acta; 1975 Sep; 63(3):323-33. PubMed ID: 240521
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 8.